Presence of Necrosis in Core Biopsy Predicts Close Margin in Ductal Carcinoma Excision Cases: Presented at ASCP
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Presence of Necrosis in Core Biopsy Predicts Close Margin in Ductal Carcinoma Excision Cases: Presented at ASCP

By John Otrompke

CHICAGO -- November 9, 2009 -- Most data gathered by needle biopsy of in situ ductal carcinoma patients are of limited value in predicting whether a subsequent breast excision will be successful, except for the amount of necrosis in the sample, according to a study presented here at the American Society for Clinical Pathology (ASCP) 2009 Annual Meeting.

“Necrosis did show a significant association with outcomes,” said Nathan F. Clement, MD, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas, on October 29. “We found that if there’s much necrosis within the needle sample, when they did the excision, they were more likely to have a close margin.”

“This means the patient likely still has some cancer in the breast,” he continued. “If the tumour is going to the edge of whatever was taken out, there’s a good chance that when they go to excise that tumour, they may not get it all out.”

“For someone who wants to excise a tumour known to have necrosis on core biopsy needs perhaps to take a wider margin, or use radiation or something that might keep them from having an incomplete surgery,” said Clement.

For the study, researchers examined 20 specimens from patients who later underwent mastectomy, and 29 who underwent breast conservation surgery, for in situ ductal carcinoma.

The specimens were examined for morphological features that may predict a close margin, defined <=0.2 cm or positive margin upon subsequent excision. Tissue from the core biopsy was compared with tissue from the surgical excision performed later.

Residual carcinoma was found in the excision in 40 out of the 49 cases. Of these, there were 5 cases in which comedo-pattern carcinoma was present in the excision but not in the core biopsy. In 28 cases, a sentinel lymph node biopsy was performed, but only 1 turned out positive.

With the exception of necrotic tissue in the needle sample, none of the other morphologic features were predictive of margin.

“We counted the number of breast ducts involved by cancer, and we counted the number of needle cores used, up to 10, but these didn’t predict whether the surgeon would have close margin,” said Dr. Clement. “Nuclear grade, which is based on the degree of atypicality of the cell nucleus upon microscope evaluation, also didn’t predict close margins.”

[Presentation title: High- and Intermediate-Grade Ductal Carcinoma In Situ of the Breast: A Comparison of Pathologic Features in Core Biopsies and Excisions and an Evaluation of Core Biopsy Features That May Predict a Close or Positive Margin in the Excision. Abstract 19]


E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities